International law firm McDermott Will & Emery represented an affiliate of H.I.G. Capital, LLC, a leading global alternative investment firm with $52 billion of equity capital under management, in its acquisition of Celerion Holdings Inc., a leading full-service provider of outsourced clinical research services to the pharmaceutical industry.

H.I.G.’s investment in Celerion adds to its active pharma services portfolio, comprising a broad spectrum across clinical research, contract manufacturing and development organizations and specialty pharmaceutical companies.

The cross-border McDermott team was led by Alex Clavero, Harris Siskind, Griffin Doty and Jun Won Kim and included Sharon Lamb, Ellie West, Daniel Zucker, Allison Wilkerson, Heidi Steele, Shawn Helms, Christian Krohs, Jerry Sokol, Mark Bilut, Greg Heltzer, David Santangelo, Gregg Fierman, Deniz Tschammler, Steffen Woitz, Nadine Hartung, Gudrun Germakowski, Sarah Bro, Scott Weinstein, Michelle Strowhiro, Jenna Young, Adam Perlman, Jason Kramer, Jeronimo Soares de Sousa, Jennifer Hill, Bella North, Simon Margesson, Max Küttner, Raja Chatterjee, Matthew Celano, Noah Feldman Green, Aurélie Chorly, Dawn Peacock, Lea Hachmeister, Kate Williams, Abigail Kagan, Lauren Evans, David Gibson, Hannelore Wiame, Alexandre Bomet and Karolien Van der Putten. The McDermott finance team included Stephanie McCann, Nicole Briody, Caitlin Harrington, Haley Caradonna, Yuxin Jin and Robin Riley.

Read H.I.G.’s press release here.

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.